| European Case Law Identifier: | ECLI:EP:BA:2016:T179111.20160407 | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Date of decision: | 07 April 2016 | ||||||||
| Case number: | T 1791/11 | ||||||||
| Application number: | 02745188.9 | ||||||||
| IPC class: | C12N 9/54 C11D 3/386 |
||||||||
| Language of proceedings: | EN | ||||||||
| Distribution: | D | ||||||||
| Download and more information: |
|
||||||||
| Title of application: | SUBTILASE VARIANTS | ||||||||
| Applicant name: | Novozymes A/S | ||||||||
| Opponent name: | Danisco US Inc. | ||||||||
| Board: | 3.3.02 | ||||||||
| Headnote: | - | ||||||||
| Relevant legal provisions: |
|
||||||||
| Keywords: | Oral proceedings - held in absence of appellant Inventive step - (no) |
||||||||
| Catchwords: |
- |
||||||||
| Cited decisions: |
|
||||||||
| Citing decisions: |
|
||||||||
Source: http://www.epo.org/law-practice/case-law-appeals/recent/t111791eu1.html
Date retrieved: 17 May 2021